Lineage Cell Therapeutics... (LCTX)
undefined
undefined%
At close: undefined
0.55
-0.62%
After-hours Jan 06, 2025, 08:00 PM EST

Lineage Cell Therapeutics Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024
Collaboration Revenues Revenue 3.39M 1.19M
Collaboration Revenues Revenue Growth +185.26% n/a

Revenue by Geography

Quarter Dec 31, 2022Dec 31, 2021Dec 31, 2020
United States Revenue 14.70M 3.90M 1.16M
United States Revenue Growth +277.48% +235.78% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 4.41M 4.36M 4.84M 4.14M 4.04M 4.25M 4.72M 4.35M 4.42M 5.27M 8.47M 4.42M 5.32M 4.54M 3.94M 3.52M 3.63M 3.91M 4.52M 4.50M 4.61M 6.26M 8.66M 7.03M 6.42M 5.23M 6.04M 5.81M 4.59M 4.42M 5.10M 5.34M 4.57M 6.64M 11.87M 10.22M 7.54M 6.19M 5.18M
Selling, General, and Administrative Revenue Growth +1.08% -9.93% +16.86% +2.57% -4.90% -10.06% +8.65% -1.67% -16.09% -37.77% +91.43% -16.80% +17.22% +15.27% +11.92% -3.09% -7.16% -13.52% +0.33% -2.28% -26.35% -27.74% +23.13% +9.51% +22.86% -13.52% +4.01% +26.68% +3.71% -13.29% -4.53% +16.81% -31.07% -44.10% +16.13% +35.49% +21.97% +19.45% n/a
Research and Development Revenue 3.17M 2.87M 2.99M 3.87M 3.74M 3.87M 4.18M 4.10M 3.59M 3.30M 2.99M 24.78M 2.81M 2.93M 3.39M 2.61M 3.57M 2.81M 3.34M 3.49M 4.27M 5.24M 4.96M 3.78M 4.88M 6.36M 5.93M 4.70M 6.56M 6.27M 6.49M 7.01M 6.42M 8.94M 13.73M 12.79M 11.43M 9.06M 9.32M
Research and Development Revenue Growth +10.56% -4.02% -22.87% +3.56% -3.41% -7.46% +1.97% +14.25% +8.78% +10.51% -87.94% +781.47% -4.09% -13.64% +30.19% -26.89% +27.13% -15.99% -4.22% -18.28% -18.51% +5.52% +31.24% -22.57% -23.21% +7.13% +26.36% -28.42% +4.64% -3.43% -7.40% +9.20% -28.15% -34.92% +7.40% +11.85% +26.21% -2.84% n/a